Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion type Assertion NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_head.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion wasGeneratedBy ECO_0000203 NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_provenance.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion wasDerivedFrom befree-20140225 NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_provenance.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion SIO_000772 9690036 NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_provenance.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion evidence source_evidence_literature NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_provenance.
- NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_assertion description "[In addition, other forms of Bartter's syndrome have been defined with mutations involving the bumetanide-sensitive sodium-potassium-chloride cotransporter (NKCC2) and the potassium channel ROMK.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264610.RATv7cxFD9ItZeVQwR-0K5f9-zxfBFttczy3-9bdYcKBE130_provenance.